A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)

被引:0
|
作者
Caponigro, F.
Franchin, G.
Rav, V.
Silvestro, G.
Morrica, B.
Romano, C.
Minatel, E.
Pepe, S.
机构
[1] Inst Natl Tumor Fdn G Pascale, Dept Med Oncol, I-33081 Naples, Italy
[2] Ctr Riferimento Oncol, Dept Radiat Oncol, Aviano, Italy
[3] Inst Natl Tumor Fdn G Pascale, Dept Radiat Therapy, Naples, Italy
[4] Univ Naples Federico II, Sch Med, Dept Mol & Clin Endocrinol, Div Med Oncol, Naples, Italy
来源
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:313 / 313
页数:1
相关论文
共 50 条
  • [1] A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck
    Caponigro, Francesco
    Romano, Carmen
    Milano, Amalia
    Solla, Raffaele
    Franchin, Giovanni
    Adamo, Vincenzo
    Mari, Ettore
    Morrica, Brunello
    Pepe, Stefano
    [J]. ANTI-CANCER DRUGS, 2008, 19 (07) : 739 - 744
  • [2] Randomized phase II trial of cisplatin and radiotherapy with or without erlotinib in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Martins, Renato
    Parvathaneni, Upendra
    Sharma, Anand K.
    Raez, Luis E.
    Papagikos, Michael A.
    Yunus, Furhan
    Bauman, Julie E.
    Eaton, Keith D.
    Liao, Jay Justin
    Mendez, Eduardo
    Futran, Neal
    Kurland, Brenda F.
    Wang, David X.
    Xiaoyu, Shawn
    Wallace, Sarah G.
    Hayes, David N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Phase I/II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Herchenhorn, D
    Dias, FL
    Araújo, CM
    Ferreira, CG
    Bezerra, M
    Hermont, P
    Lima, RA
    Porto, AL
    Pereira, CG
    Martins, RG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 523S - 523S
  • [4] Phase I/II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Herchenhorn, D.
    Dias, F. L.
    Ferreira, C. G.
    Bezerra, M.
    Fonseca, A. J.
    Mora, P.
    Pineda, R. M.
    Fontao, K.
    Knust, R. E.
    Martins, R. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 298S - 298S
  • [5] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase I/II trial
    Bonomo, P.
    Desideri, I.
    Mangoni, M.
    Loi, M.
    Saieva, C.
    Marrazzo, L.
    Talamonti, C.
    Salvatore, G.
    Sottili, M.
    Teriaca, M. A.
    Stocchi, G.
    Cerbai, C.
    Salvestrini, V.
    Ganovelli, M.
    Massi, D.
    Gallo, O.
    Santoro, R.
    Spinelli, G.
    Pallotta, S.
    Livi, L.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S686 - S686
  • [6] Phase I/II study of erlotinib (TARCEVA®) combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Fonseca, Allex J.
    Herchenhorn, Daniel
    Dias, Fernando L.
    Pineda, Rodrigo M.
    Ferreira, Carlos G.
    Bezerra, Marcos
    Knust, Renata
    Fontao, Karina
    Martins, Renato G.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 180 - 180
  • [7] Phase II study of 250 mg gefitinib in advanced squamous cell carcinoma of the head and neck (SCCHN).
    Kane, MA
    Cohen, E
    List, M
    Mehrotra, B
    Gustin, D
    Mauer, A
    Cella, D
    Vokes, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 509S - 509S
  • [8] Phase II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Herchenhorn, D.
    Dias, F. L.
    Pineda, R. M.
    Fonseca, A. J.
    Bezerra, M.
    Ferreira, C. G.
    Knust, R. E.
    Fontao, K.
    Martins, R. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck: A Phase I-II Study
    Perri, Francesco
    Muto, Paolo
    Argenone, Angela
    Ionna, Franco
    Longo, Francesco
    Fulciniti, Franco
    Sandomenico, Fabio
    Daponte, Antonio
    Caponigro, Francesco
    [J]. ONCOLOGY, 2013, 84 (04) : 251 - 254
  • [10] Phase I-II study with docetaxel (D), cisplatin (C) and 5-Fluorouracil (5-FU) in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)
    Schrijvers, D
    Van Herpen, C
    Kerger, J
    Joosens, E
    Brandely, M
    Vermorken, JB
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 75 - 75